Scienion AG and Genomica S.A. Unipersonal have introduced a jointly developed printing plate technology that will enable each company to tailor a range of microarray applications for individual IVD customers, according to the companies. The printing platform pairs noncontact arrays and surface technologies from Scienion with Genomica’s multiplex PCR technology and microarrays detection. The product introduction is the result of an ongoing collaboration between Berlin-based Scienion and its Madrid-based partner.
Holger Eickhoff, Scienion’s CEO, says the companies’ technologies “optimally complement one another.” Genomica markets DNA-based tests with CLART technology, and Scienion offers noncontact dispensing products and consumables such as microtiter plates, Eickhoff notes. CLART’s low-density, microarray-based platform allows clinicians to detect multiple targets in a single test, according to the company.
Genomica’s CEO, Rosario Cospedal, says his company’s technology has the ability “to detect specific targets with high sensitivity and specificity.” The continuing cooperation between the two life sciences firms is making it possible to identify “more subareas for joint activities,” he adds.
Scienion and Genomica plan to exhibit jointly at MEDICA 2012 in Düsseldorf, November 14–17.